The Top Three Stocks to Watch in Asia Today

The video discusses the US Navy's planned expenditure of $81.4 billion on ships and submarines, which is expected to benefit the Australian company Austal. It also covers the stock performance of Tokyo Individualized Educational Institute, highlighting its growth despite slightly missing earnings estimates. Lastly, it examines Slice Mix, a medical company that has developed a colon cancer biopsy test with Merck, recently approved in Europe, leading to significant stock growth.

What was the performance of the company's earnings per share compared to estimates?

What medical test is the company mentioned in the text developing together with Merck?